Formic Acid

Formic Acid

SCHEMBL9619062

CC(C)C(=O)O.O=CO.O=CO.O=CO.O=CO

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.47
SLC7A5 Q01650 2/20 0.38
GABRR1 P24046 2/20 0.33
RNPEP Q9H4A4 1/20 0.33
CYP1A2 P05177 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRB1 P18505 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRB2 P47870 1/20 0.33
GABRA4 P48169 1/20 0.33
GABRE P78334 1/20 0.33
GABRA6 Q16445 1/20 0.33
GABRG1 Q8N1C3 1/20 0.33
GABRG3 Q99928 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL9619061 1.00 TP53 (0.47) TP53SLC7A5GABRR1RNPEPCYP1A2
Formic Acid SCHEMBL9619050 1.00 TP53 (0.47) TP53SLC7A5GABRR1RNPEPCYP1A2
Formic Acid SCHEMBL27452140 1.00
Formic Acid SCHEMBL27540224 0.91 TP53 (0.40) TP53SLC7A5TSHRLMNAALDH1A1
Acetaldehyde SCHEMBL50446 0.86
Acetaldehyde SCHEMBL8145563 0.86 TP53 (0.47) TP53SLC7A5GABRR1RNPEPCYP1A2
SCHEMBL11267658 0.86 TP53 (0.47) TP53SLC7A5GABRR1RNPEPCYP1A2
SCHEMBL2531259 0.84 TP53 (0.61) TP53SLC7A5RNPEPCYP1A2TSHR
SCHEMBL5940223 0.84 TP53 (0.61) TP53SLC7A5RNPEPCYP1A2TSHR
SCHEMBL2774033 0.84 TP53 (0.61) TP53SLC7A5RNPEPCYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9365596-B2 Method for preparing quaternary phosphonium salts MICROVAST POWER SYSTEMS CO., LTD. (CN) 2016-06-14 US claimed
US-20150166587-A1 METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS MICROVAST POWER SYSTEMS CO., LTD. (CN) 2015-06-18 US claimed
EP-3770234-B1 DEMULSIFIER FOR QUATERNARY AMMONIUM SALT CONTAINING FUELS AFTON CHEMICAL CORP (US) 2023-11-08 EP disclosed
US-11008526-B2 Demulsifier for quaternary ammonium salt containing fuels CRODA INC. (US) 2021-05-18 US disclosed
US-20210024844-A1 DEMULSIFIER FOR QUATERNARY AMMONIUM SALT CONTAINING FUELS CRODA INC. (US) 2021-01-28 US disclosed
EP-3770234-A1 DEMULSIFIER FOR QUATERNARY AMMONIUM SALT CONTAINING FUELS Afton Chemical Corporation (US) 2021-01-27 EP disclosed
EP-2987845-B1 Use of quaternary ammonium salts in gasoline fuel to improve performance AFTON CHEMICAL CORP (US) 2018-05-09 EP disclosed
US-9677020-B2 Hydrocarbyl soluble quaternary ammonium carboxylates and fuel compositions containing them AFTON CHEMICAL CORPORATION (US) 2017-06-13 US disclosed
US-9365596-B2 Method for preparing quaternary phosphonium salts MICROVAST POWER SYSTEMS CO., LTD. (CN) 2016-06-14 US disclosed
EP-2987845-A1 Use of quaternary ammonium salts in gasoline fuel to improve performance Afton Chemical Corporation (US) 2016-02-24 EP disclosed
US-20150376524-A1 HYDROCARBYL SOLUBLE QUATERNARY AMMONIUM CARBOXYLATES AND FUEL COMPOSITIONS CONTAINING THEM AFTON CHEMICAL CORPORATION 2015-12-31 US disclosed
EP-2960319-A2 HYDROCARBYL SOLUBLE QUATERNARY AMMONIUM CARBOXYLATES AND FUEL COMPOSITIONS CONTAINING THEM Afton Chemical Corporation (US) 2015-12-30 EP disclosed
US-20150166587-A1 METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS MICROVAST POWER SYSTEMS CO., LTD. (CN) 2015-06-18 US disclosed
EP-0291074-B1 PROCESS FOR PRODUCING QUATERNARY SALTS MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1992-01-29 EP disclosed
US-4892944-A Process for producing quaternary salts MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1990-01-09 US disclosed
EP-0291074-A2 Process for producing quaternary salts MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1988-11-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166587-A1 METHOD FOR PREPARING QUATERNARY PHOSPHONIUM SALTS PHPT1, PHOSPHO1, PTEN TP53 847/4885SLC7A5 307/4885GABRR1 4113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.